Clinical Trial

« Back to List

BRE 156

Posted by: Phillip E. Baldwin, MD, Principal Investigator | Posted Date: December 31, 2012

Status: OPEN-IST
Research Hotline:
803-461-3708

Details: A Phase II Study of NK012 in Locally Advanced Non-Resectable Metastatic Breast Cancer Patients with Triple Negative Phenotype.

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share